ATP5MF-PTCD1

Across TCGA pan-cancer cohorts, ATP5MF-PTCD1 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of ATP5MF-PTCD1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where ATP5MF-PTCD1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ATP5MF-PTCD1 is over-expressed in tumor.

HNSC, LIHC, and LUSC are the cancer types where ATP5MF-PTCD1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ATP5MF-PTCD1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	III,IV	+0.091	<.001	8	view →
LIHC	All	All	+0.058	<.001	6	view →
LUSC	All	All	+0.087	.003	5	view →
KIRC	All	IV	+0.060	.011	4	view →
CHOL	All	All	+0.147	<.001	2	view →
LUAD	Female	All	+0.075	.031	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

ATP5MF-PTCD1–HNSC

Open the HNSC breakdown →